Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial
Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check15 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedSeveral key URLs related to genetics, lung cancer, and medical resources have been removed, indicating a potential shift in focus or resource availability on the website.SummaryDifference3%
- Check36 days agoChange DetectedThe website has been updated to version 2.12.2, adding numerous links to resources related to genetics, lung cancer, and various PubMed articles, while removing the previous version 2.12.1.SummaryDifference3%
- Check51 days agoChange DetectedThe website has been updated to version v2.12.1, with the removal of a resource on Cabozantinib by Andrea Ardizzoni.SummaryDifference0.6%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.